Seroatlas · Human Serome Atlas

MERTK

Tyrosine-protein kinase Mer

Also known as: c-Eyk, mer, MERTK_HUMAN, RP38, Tyro12

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q12866
Gene
MERTK
Ensembl
ENSG00000153208
Chromosome
2
Canonical length
999 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Plasma membrane,Midbody,Cytosol,Acrosome,Mid piece,Principal piece

OverviewNCBI Gene

This gene is a member of the MER/AXL/TYRO3 receptor kinase family and encodes a transmembrane protein with two fibronectin type-III domains, two Ig-like C2-type (immunoglobulin-like) domains, and one tyrosine kinase domain. Mutations in this gene have been associated with disruption of the retinal pigment epithelium (RPE) phagocytosis pathway and onset of autosomal recessive retinitis pigmentosa (RP). [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

999 residues, UniProt reviewed canonical sequence.

>Q12866|MERTK
     1  MGPAPLPLLL GLFLPALWRR AITEAREEAK PYPLFPGPFP GSLQTDHTPL LSLPHASGYQ
    61  PALMFSPTQP GRPHTGNVAI PQVTSVESKP LPPLAFKHTV GHIILSEHKG VKFNCSISVP
   121  NIYQDTTISW WKDGKELLGA HHAITQFYPD DEVTAIIASF SITSVQRSDN GSYICKMKIN
   181  NEEIVSDPIY IEVQGLPHFT KQPESMNVTR NTAFNLTCQA VGPPEPVNIF WVQNSSRVNE
   241  QPEKSPSVLT VPGLTEMAVF SCEAHNDKGL TVSKGVQINI KAIPSPPTEV SIRNSTAHSI
   301  LISWVPGFDG YSPFRNCSIQ VKEADPLSNG SVMIFNTSAL PHLYQIKQLQ ALANYSIGVS
   361  CMNEIGWSAV SPWILASTTE GAPSVAPLNV TVFLNESSDN VDIRWMKPPT KQQDGELVGY
   421  RISHVWQSAG ISKELLEEVG QNGSRARISV QVHNATCTVR IAAVTRGGVG PFSDPVKIFI
   481  PAHGWVDYAP SSTPAPGNAD PVLIIFGCFC GFILIGLILY ISLAIRKRVQ ETKFGNAFTE
   541  EDSELVVNYI AKKSFCRRAI ELTLHSLGVS EELQNKLEDV VIDRNLLILG KILGEGEFGS
   601  VMEGNLKQED GTSLKVAVKT MKLDNSSQRE IEEFLSEAAC MKDFSHPNVI RLLGVCIEMS
   661  SQGIPKPMVI LPFMKYGDLH TYLLYSRLET GPKHIPLQTL LKFMVDIALG MEYLSNRNFL
   721  HRDLAARNCM LRDDMTVCVA DFGLSKKIYS GDYYRQGRIA KMPVKWIAIE SLADRVYTSK
   781  SDVWAFGVTM WEIATRGMTP YPGVQNHEMY DYLLHGHRLK QPEDCLDELY EIMYSCWRTD
   841  PLDRPTFSVL RLQLEKLLES LPDVRNQADV IYVNTQLLES SEGLAQGSTL APLDLNIDPD
   901  SIIASCTPRA AISVVTAEVH DSKPHEGRYI LNGGSEEWED LTSAPSAAVT AEKNSVLPGE
   961  RLVRNGVSWS HSSMLPLGSS LPDELLFADD SSEGSEVLM

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against MERTK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.4
Highest tissue expression
90 nTPM

Expression across tissuesHPA

Tissue

  • choroid plexus: 90 nTPM
  • adrenal gland: 56 nTPM
  • blood vessel: 31 nTPM
  • spleen: 29 nTPM
  • epididymis: 25 nTPM
  • parathyroid gland: 20 nTPM

Single-cell type

  • kupffer cells: 733 nCPM
  • macrophages: 428 nCPM
  • microglia: 379 nCPM
  • pituicytes/fscs: 248 nCPM
  • adrenal cortex cells: 246 nCPM
  • astrocytes: 224 nCPM

Immune cell

  • intermediate monocyte: 8.7 nTPM
  • non-classical monocyte: 5.5 nTPM
  • classical monocyte: 0.6 nTPM
  • total PBMC: 0.2 nTPM
  • myeloid DC: 0.1 nTPM
  • neutrophil: 0.1 nTPM

Brain region

  • choroid plexus: 72 nTPM
  • thalamus: 41 nTPM
  • basal ganglia: 37 nTPM
  • cerebral cortex: 37 nTPM
  • medulla oblongata: 28 nTPM
  • amygdala: 27 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about MERTK.

Disease | AllUniProt

Conditions MERTK is implicated in, by any mechanism.

Disease | GeneticClinVar

128 pathogenic / likely-pathogenic of 903 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.75
gnomAD pLI
0
gnomAD missense Z
0.59
DepMap mean gene effect
-0.11
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of MERTK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads MERTK as an antibody target. Whether an autoantibody or antibody against MERTK could matter depends on whether native MERTK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

MERTK is annotated at the cell surface, where native MERTK is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label MERTK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/MERTK. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...